· Dr Sim is a senior consultant urologist at Gleneagles Hospital Singapore and currently serves as chairman, Chapter of Urologists at the College of Surgeons and Academy of Medicine, Singapore, and EXCO member of Singapore Urological Association. He is also the secretary-general of the Asia-Pacific Society of Urologic Oncology and an advisory member of the Asian Society of Robotic Surgery and an active member of both the Singapore and American Urological Associations and the Society of Urologic Oncology (Chicago, Illinois, USA). · Dr Sim has research interests in genitourinary cancer, especially in prostate cancer biomarkers and cancer epigenetics and received research funding from National Medical Research Council (NMRC) and Singhealth Research Foundation. He was also a collaborator for many translational and clinical research studies involving multi-centre randomised controlled trials since 2001. · Dr Sim completed a 2-year Society of Urologic Oncology fellowship in USA where he pursued further urology training in the management of kidney, bladder, prostate, testis and penile cancers at the University of Washington Medical Centre and Fred Hutchinson Cancer Research Center. Dr Sim was the first urologist in Singapore and Southeast Asia to be certified by the Society of Urologic Oncology in the management of genito-urinary cancers. · Prior to his current practice, Dr Sim was the director of Urologic Oncology at Singapore General Hospital and director of Clinical Database & Outcomes Research in Singhealth. He was an adjunct assistant professor of urology at Duke-NUS Graduate Medical School, clinical lecturer and MBBS examiner for Surgery track at the National University of Singapore Yong Loo Lin School of Medicine, and programme director for the Singhealth Urology residency training programme. He is an examiner for urology residents in Singapore. · Dr Sim is recognised by his peers to be an expert in genito-urinary cancer surgery. He is conversant with open, laparoscopic and robot-assisted surgical approaches to cancer. He was involved in laparoscopic adrenal and kidney surgery since 2001. He is certified by Intuitive Surgical Inc in Sunnyvale California, USA, to handle the robotic surgical system and was a key member of the original surgical team that started the robotic surgery revolution in Asia in 2002. In 2007, he introduced ultrasound guided peri-prostatic anaesthesia to minimise discomfort in men undergoing prostate biopsies and in 2009, he introduced robot-assisted partial nephrectomy for small kidney cancers in Singapore. Dr Sim also introduced robot-assisted radical cystectomy in 2011. · Dr Sim was the chairman of the Singapore Prostate cancer management guidelines committee in 2012 and sits on the Asian advisory panel for the National Comprehensive Cancer Network Prostate and Bladder cancer guidelines. He was a member of the Ministry of Health prostate cancer screening guidelines committee in 2008. He was also a panel member for the kidney cancer management guidelines at the Asian Oncology Summit in 2012. He has been invited as a speaker in Urology at several conferences in Southeast Asia, China and USA, and has mentored several generations of local urologists and overseas clinical fellows.
uro surgery